September 17, 2026
HNUC offers real revenue and a federal loan backstop, but the restart timeline has already moved.
Tonight Holtec Nuclear is expected to price 50 million shares at $15 to $18 apiece, aiming to raise up to $900 million and list tomorrow on Nasdaq under HNUC, valuing the company at as much as $10.2 billion. The debut lands the morning after a Federal Reserve rate decision, into quad witching. The central question for anyone sizing a position: does the bull case on Palisades hold up against a restart timeline that has already moved more than once?
J.P. Morgan Is Building on This Under-$1 Crypto
While fear hits levels not seen since 2022, major institutions aren’t backing off – they’re building. One little-known crypto is being used for real infrastructure tied to moving traditional assets on-chain. With supply tightening and activity expected to rise, this setup is getting harder to ignore.
Get the full breakdown on this under-$1 crypto before attention grows
The Bull Case
What separates Holtec from most nuclear companies coming public is that it already has an operating business generating real revenues. In the first half of 2026 the company generated $269.9 million in revenue, with gross operating margin improving to 43.9% from 27.5% a year earlier, and held roughly $1.5 billion of remaining performance obligations. That is not a pre-revenue speculation play.
Holtec holds 203 granted patents worldwide as of June 30, 2026, operates three U.S.-based manufacturing facilities, and has provided products and services to more than 150 nuclear reactors worldwide. The services backbone funds the Palisades bet without depending on it.
On the Palisades restart itself, momentum is real. On August 31, Holtec said fuel loading into the Palisades reactor had begun, marking another step toward what would be the first restart of a closed-down unit in U.S. history. Holtec CEO Kris Singh has said publicly he expects Palisades to restart this year, ahead of its contract to supply power by March 2027. Federal support has not wavered: the Palisades restart is backed by a U.S. Department of Energy loan of up to $1.52 billion.
SpaceX S-1 Filing Reveals Elon’s Hidden AI Master Plan
Wall Street completely missed the most important part of the largest IPO in history.
Buried inside the S-1 filing is something that could be worth far more than the entire rocket business – unlike anything we’ve seen before.
Rob Spivey – whose institutional research is followed by Goldman Sachs, JPMorgan Chase, BlackRock, and Fidelity – just went on location at SpaceX’s Starbase HQ to reveal everything he has discovered about Elon’s hidden master plan.
The last time Wall Street missed a story this big, early investors had the chance to turn every $1,000 into $14,000.
Get the name and ticker of the No. 1 stock at the center of it FREE (not Tesla or SpaceX).
Beyond Palisades, Holtec has developed the SMR-300, a Generation III+ pressurized water small modular reactor design, and plans to deploy an initial dual-unit installation at the Palisades site in partnership with Hyundai Engineering and Construction under a build-own-and-operate model. Its small modular reactor project was also awarded up to $400 million in cost-shared funding from the U.S. Department of Energy. The SMR pipeline broadens the long-term earnings surface well beyond a single 800 MW restart.
The Bear Case
The timeline question is not theoretical. Palisades was supposed to restart in October 2025, yet that date continued to be delayed by a slew of issues. When the DOE loan closed in September 2024, expectations centered on a late 2025 restart. As that deadline passed, mechanical and regulatory work extended the target into 2026, with each update adding a few more months.
One reason investors keep circling the same concern is steam generator condition. Holtec has described a refurbishment program and has, at various points, pointed to repair approaches rather than wholesale replacement. Critics argue tube-level repairs can look like a workaround, not a solution.
Then there is the governance structure. Holtec Holdings will control a majority of the company’s voting power, making HNUC a controlled company under Nasdaq governance standards. Minority shareholders have price exposure with almost no governance influence. Any valuation contribution from the SMR-300 rests on future regulatory approvals, financing, construction, and commercial execution rather than current operating cash flow. At $10.2 billion, the market is being asked to price in a great deal that has not happened yet.
A Forgotten Energy Source Is Powering Back Up
While investors chase the next tech story, one long-ignored sector is quietly heating up. A mix of global policy, rising demand, and tightening supply could reignite this market before 2026. See what the latest research reveals.
Where the Evidence Leads
The services business is genuinely profitable, the DOE backing is real, and fuel loading at Palisades represents the most tangible progress yet. Those facts support a credible bull argument. The bear argument, however, rests on something equally tangible: no U.S. commercial reactor has ever returned to operation after a permanent shutdown and the start of decommissioning. Every optimistic deadline Holtec published has since moved. Palisades would become the first commercial nuclear reactor in the United States to return to operation after a permanent shutdown, if it succeeds. The word “if” still carries weight.
What Could Change the Debate
The single most important catalyst is Palisades achieving first criticality. That event, when the reactor sustains a controlled nuclear chain reaction, would remove the “unprecedented” risk premium and validate the restart thesis concretely. Watch also for SMR-300 licensing progress at the NRC and whether the data center power demand that is driving the whole nuclear sector continues to pull forward procurement timelines. On the bear side, any further mechanical delay or a new NRC inspection finding would pressure the stock on a day when the float is thin and the market is already moving fast into quad witching.
Final Verdict
The bull case is better supported today than it was six months ago: fuel is going into the core, the services business is generating real cash, and the institutional syndicate behind this deal is among the strongest assembled for a nuclear listing. But the $10.2 billion valuation prices in a restart that has not yet occurred and an SMR program that remains years from revenue. The edge goes narrowly to the bull side, with the critical caveat that Palisades reaching commercial operation on anything close to the current schedule is the load-bearing assumption in every optimistic scenario. Investors buying tomorrow are making a bet that this time, the timeline holds.
